Dracen Pharmaceuticals, Inc. has raised $2.3M in total funding. The most recent round was Series A.
Dracen Pharmaceuticals, Inc. is headquartered in San Diego, CA.
Founded by Thomas Estok and Dr. Mohamed Ragab, the cancer-drug developer has raised about $59M from investors including Deerfield Management and i&i Biotech Fund.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.